GAMMA Investing
UTMD icon

GAMMA Investing’s Utah Medical Products UTMD Stock Holding History

GAMMA Investing’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.4K Buy
275
+50
+22% +$3.56K ﹤0.01% 2939
2026
Q2 		$15.5K Buy
225
+88
+64% +$5.85K ﹤0.01% 2976
2026
Q1 		$8.49K Buy
137
+66
+93% +$4.16K ﹤0.01% 3157
2025
Q4 		$3.97K Sell
71
-51
-42% -$2.96K ﹤0.01% 3376
2025
Q3 		$7.68K Buy
122
+99
+430% +$5.86K ﹤0.01% 3000
2025
Q2 		$1.31K Sell
23
-49
-68% -$2.66K ﹤0.01% 3486
2025
Q1 		$4.04K Buy
72
+69
+2,300% +$4.13K ﹤0.01% 3169
2024
Q4 		$184 Sell
3
-26
-90% -$1.68K ﹤0.01% 3714
2024
Q3 		$1.94K Buy
+29
New +$1.97K ﹤0.01% 3078
2024
Q1 		– Sell
-1
Closed -$79 – 3373
2023
Q4 		$79 Buy
+1
New +$83 ﹤0.01% 3151

Other funds holding UTMD

Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing's UTMD Position: Q3 2026 in Review

GAMMA Investing increased its Utah Medical Products (UTMD) stake by 22% in Q3 2026, buying an estimated $3.56K and bringing the position to 275 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2939.

GAMMA Investing first reported a position in UTMD in Q4 2023 and has held it in 10 quarters since. 13 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • GAMMA Investing held 275 shares of Utah Medical Products worth $20.4K as of Q3 2026.
  • GAMMA Investing bought 50 Utah Medical Products shares in Q3 2026, an estimated $3.56K.
  • Utah Medical Products made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2939 holding.
  • GAMMA Investing first reported a position in Utah Medical Products in Q4 2023 and has held it in 10 quarters since.
  • 13 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.